Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Thermo Fisher Closes Phadia Deal
Aug 2011
WALTHAM, Mass., Aug. 23, 2011 — Thermo Fisher Scientific Inc. has completed the acquisition of Phadia of Uppsala, Sweden, a provider of blood tests for the clinical diagnosis and monitoring of allergies and autoimmune diseases.

Phadia now is part of Thermo Fisher’s Specialty Diagnostics business. The company is expected to contribute $0.07 to Thermo Fisher’s 2011 full-year adjusted earnings per share (EPS), an increase of $0.01 over the original estimate. Because of the favorable financing rates for the fourth quarter, the US company has adjusted its full-year EPS, which could result in a 20% to 23% EPS growth over 2010, it said.

In addition, Phadia is expected to add $190 million to the company’s 2011 revenue results, about a 12% growth in revenue over 2010.

For more information, visit:  

AmericasBiophotonicsblood test monitoringblood tests for clinical diagnosisBusinessearnings per shareEPSEuropeMassachusettsPhadiaSwedentesting for allergies and autoimmune diseasesThermo FisherThermo Fisher ScientificThermo Fisher Specialty Diagnostics

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.